货号:A593928
同义名:
刺五加甙E
/ Syringin E
Eleutheroside E是五味子(Eleutherococcus senticosus)的主要成分,在缺血性心脏病中具有抗炎和保护作用。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Eleutheroside E (EE), a principal component of Eleutherococcus senticosus (ES), has anti-inflammatory and protective effects in ischemia heart. EE increased the insulin-provoked glucose uptake in C2C12 myotubes. Moreover, EE improved TNF- α -induced suppression of glucose uptake in 3T3-L1 adipocytes. EE mediates the hyperglycemic effects of ES by regulating insulin signaling and glucose utilization[3]. The IC50 values for EB and EE were calculated to be 193.20 μM and 188.36 μM for CYP2E1, 595.66 μM and 261.82 μM for CYP2C9, respectively[4]. EE administration attenuated the cardiomyocyte apoptosis induced by hypoxia-reoxygenation (H/R) injury. Further, pre-treatment with EE dramatically inhibited mitochondrial oxidative stress, IκBα phosphorylation and nuclear factor kappa B (NF-κB) subunit p65 translocation into nuclei. EE might suppress the MAPK signaling pathway to inhibit the H/R-induced NF-κB activation. EE may be a potential drug for myocardial I/R injury by reducing oxidative stress, NF-κB activation, and metabolic reprogramming[5]. |
| Concentration | Treated Time | Description | References | |
| PC12 cells | 100, 10, 1, 0.1 mg/mL | 24 hours | To evaluate the effect of Eleutheroside E on PC12 cell viability, results showed no significant effect on PC12 cell viability | Neural Regen Res. 2012 Aug 25;7(24):1845-50 |
| PC-12 cells | 100 μmol/L, 300 μmol/L, 500 μmol/L | 24 hours | To investigate the protective effect of Eleutheroside E on the MPTP-induced Parkinson’s disease cell model. Results showed that compared with the MPTP group, the survival rates of cells at low, medium, and high concentrations of eleutheroside E all increased. The mitochondrial membrane potential at medium and high concentrations of eleutheroside E increased. The ROS levels at medium and high concentrations of eleutheroside E decreased. Moreover, the apoptosis rate decreased and the expression levels of the intracellular proteins CytC, Nrf2, and NQO1 were upregulated. | Molecules. 2023 Apr 29;28(9):3820 |
| Administration | Dosage | Frequency | Description | References | ||
| Kunming mice | 60Co-γ radiation model | Oral | 50 mg/kg/d | Once daily for 4 weeks | Eleutheroside E supplementation improved cognition and spatial memory impairments in irradiated mice, protected hippocampal neurons, remodeled gut microbiota, especially changes in Lactobacillus and Helicobacter, and altered microbial metabolites including neurotransmitters (GABA, NE, ACH, 5-HT) and their precursors. Furthermore, fecal transplantation from EE donors verified that EE alleviated cognition and spatial memory impairments and activated the PKA/CREB/BDNF signaling pathway via gut microbiota. | Commun Biol. 2022 Jul 8;5(1):680 |
| Wistar rats | Ovariectomized osteoporosis model | Oral | 0.1g/kg | Once daily for 4 weeks | To evaluate the therapeutic effect of Eleutheroside E on ovariectomized osteoporosis model rats, it was found to significantly regulate 21 biomarkers, mainly involving steroid hormone biosynthesis, arachidonic acid metabolism, and primary bile acid biosynthesis. | Front Pharmacol. 2020 Aug 26;11:1316 |
| Wistar rats | Ovariectomized osteoporosis model | Oral | 0.1g/kg | Once daily for 4 weeks | Evaluate the intervention effect of Eleutheroside E on ovariectomized osteoporosis model rats, regulating 21 biomarkers, mainly involving steroid hormone biosynthesis, arachidonic acid metabolism, and primary bile acid biosynthesis | Front Pharmacol. 2020 Aug 26;11:1316 |
| Rats | Cerebral ischemia-reperfusion injury model | Gavage | 10 mg/kg | Once daily for 21 days | To evaluate the protective effect of Eleutheroside E on cerebral ischemia-reperfusion injury, results showed that Eleutheroside E significantly reduced cerebral infarct volume and improved neurological deficits. | Bioengineered. 2022 May;13(5):11718-11731 |
| Kunming mice | Radiation-induced brain injury model | Intragastric administration | 204.6 μg/kg/d | Once daily for 14 days | Eleutheroside E significantly improved learning and memory ability impairment in irradiated mice, protected neurons, increased antioxidant activity, and regulated neurotransmitter levels. | Molecules. 2022 Feb 7;27(3):1106 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.35mL 0.27mL 0.13mL |
6.73mL 1.35mL 0.67mL |
13.46mL 2.69mL 1.35mL |
|
| CAS号 | 39432-56-9 |
| 分子式 | C34H46O18 |
| 分子量 | 742.72 |
| SMILES Code | COC(C=C1[C@H]2[C@@](CO[C@@H]3C4=CC(OC)=C(O[C@@H]([C@@H]([C@@H](O)[C@@H]5O)O)O[C@@H]5CO)C(OC)=C4)([H])[C@]3([H])CO2)=C(C(OC)=C1)O[C@@H]([C@@H]([C@@H](O)[C@@H]6O)O)O[C@@H]6CO |
| MDL No. | MFCD20036283 |
| 别名 | 刺五加甙E ;Syringin E |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(141.37 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 1 mg/mL(1.35 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1